3rd Quarter - Report — DUTKO WORLDWIDE, LLC for ABBOTT LABORATORIES (2009)

Firm

DUTKO WORLDWIDE, LLC

Client

ABBOTT LABORATORIES

Income

$30,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Monitor federal legislation related to health care IP issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (H.CON.RES.85/ S.CON.RES.13), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Also: America's Affordable Health Choices Act of 2009 (H.R. 3200), Senate HELP Committee mark (no bill number assigned), Senate Finance Committee mark (no bill number assigned). Pharmaceutical import safety legislation. Food Safety Enhancement Act of 2009 (H.R.2749).

Lobbyist	Covered position, as disclosed
DARREN WILLCOX	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1548 (111th), H.Con.Res. 85 (111th), H.R. 2749 (111th), H.R. 1 (111th), H.R. 3200 (111th), S. 515 (111th), H.R. 1260 (111th), S. 610 (111th), S.Con.Res. 13 (111th)

Health Issues HCR

Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (H.CON.RES.85/ S.CON.RES.13), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Also monitored: America's Affordable Health Choices Act of 2009 (H.R. 3200), Senate HELP Committee mark (no bill number assigned), Senate Finance Committee mark (no bill number assigned). Pharmaceutical import safety legislation. Food Safety Enhancement Act of 2009 (H.R.2749).

Lobbyist	Covered position, as disclosed
DARREN WILLCOX	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1 (111th), S.Con.Res. 13 (111th), H.R. 1260 (111th), H.Con.Res. 85 (111th), H.R. 1548 (111th), H.R. 3200 (111th), S. 515 (111th), S. 610 (111th), H.R. 2749 (111th)

Medicare/Medicaid MMM

Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (H.CON.RES.85/ S.CON.RES.13), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. America's Affordable Health Choices Act of 2009 (H.R. 3200), Senate HELP Committee mark (no bill number assigned), Senate Finance Committee mark (no bill number assigned). Pharmaceutical import safety legislation. Food Safety Enhancement Act of 2009 (H.R.2749).

Lobbyist	Covered position, as disclosed
DARREN WILLCOX	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S.Con.Res. 13 (111th), H.R. 1548 (111th), H.Con.Res. 85 (111th), H.R. 1260 (111th), H.R. 1 (111th), S. 610 (111th), H.R. 3200 (111th), S. 515 (111th), H.R. 2749 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.